Shilpa Medicare share price extended gains on sixth consecutive session, rising 3 percent in the opening trade on May 15 following the company received Establishment Inspection Report (EIR) from United State Food and Drug Administration (USFDA).At 09:26am, Shilpa Medicare was quoting at Rs 715.55, up Rs 21.40, or 3.08 percent, on the BSE.Shilpa Medicare's subsidiary, Shilpa Pharma Lifesciences, Un...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, appointments and order wins, here’s a quick look at which stocks will be in focus in today's trade:Results TodayLIC Housing Finance, PB Fintech, Abbott India, Allied Blenders and Distillers, Balrampur Chini Mills, CESC, Crompton Greaves Consumer Electricals, Endurance Technol...

The Nifty and Bank Nifty indices, which staged a sharp rebound from their March lows, are showing signs of exhaustion and are likely to break below previous troughs, technical strategist Sushil Kedia has said. Despite the recent breathtaking rally - a hallmark of bear market structures - technical patterns suggest markets are entering a fresh sell-off phase, Kedia added.The veteran investor said t...

Shares of Shilpa Medicare gained over 2 percent to Rs 647 in morning trade on March 18 after its subsidiary, Shilpa Biologicals, signed a strategic partnership with Switzerland-based mAbTree Biologics AG to co-develop and manufacture a novel immuno-oncology therapy.Under the agreement, Shilpa Biologicals will handle the drug’s development, including clinical trials, and serve as the long-term co...

Let's catch up on the latest news from the stock market. From significant investments to major deals, order wins, appointments, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:Stocks to WatchIndusInd BankMoody’s Ratings has affirmed IndusInd Bank's credit ratings, placing the Baseline Credit Assessment (BCA) on review for downgrade. The rating agency mai...